Commercialization: Page 115
-
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Pharmaceutical Companies Rethink Consumer Marketing Strategies in 2005 Facing increased scrutiny from the federal government and the public, pharmaceutical companies are looking beyond direct-to-consumer (DTC) marketing to more effective...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Facing industry challenges Healthcare advertising agencies, service providers, and companies offering strategic consulting to pharmaceutical and life-sciences companies are grappling with the challenges facing their clients: shrinking profit margins, fewer drugs in the pipeline, consolidation, he...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Making metrics matter: The changing paradigm of R&D metrics As the pharma industry comes under greater scrutiny, everything from discovery processes to R&D productivity to profit margins is subject to review. Metrics systems are being implemented to realize efficiencies and b...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
ISB and IBM launch Human Proteome Folding Project on World Community Grid The Institute for Systems Biology (ISB), in partnership with IBM, United Devices, and the University of Washington, has launched the Human Proteome Folding Project on World Community Grid. This project, the first to run on ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
HMP Launches Arthritis Practitioner HMP Communications is launching Arthritis Practitioner in May 2005. The publication will have editions in July, September, and November. The journal’s audience is comprised of more than 32,000 nurse practitioners and physician assistants that are profiled as hi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Opinions Leadership Development In demanding times, leadership is a competitive edge. Good leaders provide opportunities for others to grow their communication, decision-making, problem-solving, and other related skills. Leading is setting direction and guiding others to follow that direction. Go...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
Agency Veterans Launch Flashpoint Medica The agency’s mission is to ignite and spark new opportunities in pharmaceutical marketing. Risa Bernstein and Charlene Prounis are once again embracing the entrepreneurial spirit through the cofounding and launch of Flashpoint Medica, an agency with a pass...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
-
PharmaVoice Team/PharmaVoice
What's New
inChord Establishes The Navicor Group New agency to offer expertise in oncology and immunology. inChord Communications Inc. has launched The Navicor Group, a new advertising agency focused exclusively on companies marketing oncology and immunology products. “Today there are more cancer therapies ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Drug Importation Poses Risks A federal HHS Task Force has warned in its Report on Prescription Drug Importation against the public health risks and economic effects of legalizing the importation of drugs from Canada and other countries with price controls. “This study confirms the deep flaws inhe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Pharma’s Clouds Aren’t Darkening the Employee Recruitment Outlook Contributed by Julie B. Kampf Massive product safety recalls; costly accounting and pricing violations; embarrassing marketing and sales transgressions — is the beleaguered pharmaceutical sector an executive recruiter’s nightmare? ...
By Julie B. Kampf • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar April 17-19 Medical Manufacturing Summit The Homestead Resort, Hot Springs, Va. For more information, contact Caria Badenhorst, Marcus Evans, at 246-417-5321, e-mail [email protected], or visit medicalmanufacturingsummit.com. April 18-19 Neurodegeneration in Alzheimer’s, Pa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Alan Colowick Threshold Pharmaceuticals Appoints Chief Medical Officer Threshold Pharmaceuticals has named Alan Colowick, M.D., chief medical officer. Threshold Pharmaceuticals, Redwood City, Calif., is focused on the discovery, development, and commercialization of small-molecule...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The PC Approach to Improving the Detail
The Tablet PC is starting to gain more traction in the pharmaceutical industry, particularly as a tool for sales reps during a detail. While concerns over price, size, and user-friendliness remain, industry experts predict their use will continue to increase.ime is not on their side. Pharmaceutic...
By Lisa Dress • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Relationship building As a veteran public-relations professional, long-time volunteer, and current member of the American Cancer Society (ACS), Eastern Division Board, serving New York and New Jersey, I would like to comment on Roger Sullivan’s letter (published in October 2004) in response to th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Preferred-provider status Increasingly, companies that provide services to the life-sciences industry are required to be on a preferred provider list. In the November issue of PharmaVOICE, we asked are innovative/new ideas being overlooked in some cases because a serv...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
December 2003 Contents 8 Cyndi Verst-Brasch says Phase IV trials have to withstand regulatory vigor. 20 Pharma is becoming more involved in choosing investigator sites, says Mark Eisenach. 32 For Dr. John Patton, the life sciences are awe inspiring. on the cover The value of Phase IV Postmarketin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies DVC Healthcare Launches Relationship- Marketing Practice DVC HealthCare, a division of DVC Worldwide, has expanded its service offerings to include a comprehensive relationship-marketing solution. The tool expands DVC’s ability to focus on ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
letter from the editor Phase IV studies can help differentiate a product from its competitors, medically support marketing objectives and messages, develop and enhance relationships with clinical investigators and key opinion leaders, increase physician exposure to a new drug, answer scientific q...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
The use of humor in pharmaceutical advertising, whether it is a professional or direct-to-consumer campaign, requires a delicate balance. But if done properly and with sensitivity, a light-hearted approach can separate the generic from the exceptional. Ted Whitby, senior VP and creative director ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for transformational product marketing Lena Chow Lena Chow, founder of Lena Chow Advertising, and former chairman, chief strategic officer of Euro RSCG Life, discusses the challenges of implementing successful marketing campaigns for transformational products. A New Generation of He...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Today the pharmaceutical industry faces the challenge of deploying products in an increasingly competitive and cut-throat environment. As a result, there is enormous pressure to achieve maximum return on investment before patents expire. In addition, as patents on mega-blockbusters expire, the ph...
By PharmaVoice Team • Jan. 2, 2008
Previous
